Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by cjdavid1on Jan 18, 2014 10:46am
181 Views
Post# 22107297

RE:RE:Waiting for International collaboration from deep pockets

RE:RE:Waiting for International collaboration from deep pocketsGood questions. It really depends on many factors. Some major ones being Brilliant Minds, Money, Pipeline, Testing phases, Gov't Approvals, Connections, and possibility of "Fast-Tracking". MRK, BMY, and many other Oncology Co.s have a place in line. This is why the conferences hold so much promise for partnering. I can only refer you back to the sites I posted previously. There are many more, but I saved those 3 because of their potential reach.

Should you find others worth noting, post them here.

GLTA
Cj
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse